Beth A. O'leary
Kingston, ACT, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis.
Journal: Journal of managed care & specialty pharmacy
Published: June 14, 2021
Comparison of the effect of lemborexant and other insomnia treatments on driving performance: a systematic review and meta-analysis.
Journal: Sleep advances : a journal of the Sleep Research Society
Published: April 19, 2021
The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 05, 2016
Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysis.
Journal: Journal of diabetes
Published: August 26, 2015
Single-ARM Studies to Support Drug Reimbursement in Australia.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
The Impact of Mutliple Sclerosis Severity on Quality of Life, Stress, Depression and Social Support Needs.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
The economic impact of multiple sclerosis in Australia in 2010.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 09, 2013
A novel method for calculating prevalence of multiple sclerosis in Australia.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 17, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026